Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free CDIOW Stock Alerts

Cardio Diagnostics (CDIOW) Competitors

Cardio Diagnostics logo
$0.02 0.00 (0.00%)
As of 08/5/2026 03:51 PM Eastern
Compare

CDIOW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy Cardio Diagnostics stock or one of its competitors? MarketBeat compares Cardio Diagnostics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cardio Diagnostics include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). These companies are all part of the "biotechnology" industry.

How does Cardio Diagnostics compare to Alvotech?

Cardio Diagnostics (NASDAQ:CDIOW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

In the previous week, Cardio Diagnostics had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for Cardio Diagnostics and 0 mentions for Alvotech. Cardio Diagnostics' average media sentiment score of 0.98 beat Alvotech's score of 0.67 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Positive
Alvotech Positive

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Alvotech N/A N/A N/A

Summary

Cardio Diagnostics beats Alvotech on 2 of the 3 factors compared between the two stocks.

How does Cardio Diagnostics compare to Apollomics?

Cardio Diagnostics (NASDAQ:CDIOW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

In the previous week, Cardio Diagnostics had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for Cardio Diagnostics and 0 mentions for Apollomics. Cardio Diagnostics' average media sentiment score of 0.98 beat Apollomics' score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Positive
Apollomics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Cardio Diagnostics beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does Cardio Diagnostics compare to Aravive?

Cardio Diagnostics (NASDAQ:CDIOW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

In the previous week, Cardio Diagnostics had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Cardio Diagnostics and 0 mentions for Aravive. Cardio Diagnostics' average media sentiment score of 0.98 beat Aravive's score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Positive
Aravive Neutral

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Aravive N/A N/A N/A

Summary

Cardio Diagnostics beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Cardio Diagnostics compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.61MN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

In the previous week, Cardio Diagnostics had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 1 mentions for Cardio Diagnostics and 0 mentions for bioAffinity Technologies. Cardio Diagnostics' average media sentiment score of 0.98 beat bioAffinity Technologies' score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the news media.

Company Overall Sentiment
bioAffinity Technologies Neutral
Cardio Diagnostics Positive

Summary

Cardio Diagnostics beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

How does Cardio Diagnostics compare to BioVie?

Cardio Diagnostics (NASDAQ:CDIOW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

In the previous week, Cardio Diagnostics had 1 more articles in the media than BioVie. MarketBeat recorded 1 mentions for Cardio Diagnostics and 0 mentions for BioVie. Cardio Diagnostics' average media sentiment score of 0.98 beat BioVie's score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Positive
BioVie Neutral

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
BioVie N/A N/A N/A

Summary

Cardio Diagnostics beats BioVie on 3 of the 3 factors compared between the two stocks.

Get Cardio Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDIOW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDIOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDIOW vs. The Competition

Export
MetricCardio DiagnosticsBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.61B$6.95B$12.87B
Dividend YieldN/A3.77%2.59%9.94%
P/E RatioN/A8.32270.8225.30
Price / SalesN/A1,294.25600.1582.65
Price / CashN/A101.3771.8950.37
Price / BookN/A17.6413.006.13
Net IncomeN/A-$13.22M$3.46B$342.95M
7 Day PerformanceN/A4.45%3.39%3.19%
1 Month PerformanceN/A-4.89%-2.69%-1.98%
1 Year PerformanceN/A56.58%75.98%21.11%

Cardio Diagnostics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDIOW
Cardio Diagnostics
N/A$0.02
flat		N/A+18.9%$0.00$16.57KN/A7
ALVOW
Alvotech
N/A$0.15
flat		N/AN/A$0.00$559.42MN/A4
APLMW
Apollomics
N/A$0.02
+5.2%		N/A-29.9%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.07
-30.6%		N/A-65.6%$0.00$5.61MN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CDIOW) was last updated on 8/7/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel